首页> 美国卫生研究院文献>Materials >Continuous-Flow Production of Injectable Liposomes via a Microfluidic Approach
【2h】

Continuous-Flow Production of Injectable Liposomes via a Microfluidic Approach

机译:通过微流控方法连续生产可注射脂质体

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Injectable liposomes are characterized by a suitable size and unique lipid mixtures, which require time-consuming and nonstraightforward production processes. The complexity of the manufacturing methods may affect liposome solubility, the phase transition temperatures of the membranes, the average particle size, and the associated particle size distribution, with a possible impact on the drug encapsulation and release. By leveraging the precise steady-state control over the mixing of miscible liquids and a highly efficient heat transfer, microfluidic technology has proved to be an effective and direct methodology to produce liposomes. This approach results particularly efficient in reducing the number of the sizing steps, when compared to standard industrial methods. Here, Microfluidic Hydrodynamic Focusing chips were produced and used to form liposomes upon tuning experimental parameters such as lipids concentration and Flow-Rate-Ratios (FRRs). Although modelling evidenced the dependence of the laminar flow on the geometric constraints and the FRR conditions, for the specific formulation investigated in this study, the lipids concentration was identified as the primary factor influencing the size of the liposomes and their polydispersity index. This was attributed to a predominance of the bending elasticity modulus over the vesiculation index in the lipid mixture used. Eventually, liposomes of injectable size were produced using microfluidic one-pot synthesis in continuous flow.
机译:可注射脂质体的特征在于合适的大小和独特的脂质混合物,这需要耗时且不直接的生产过程。制造方法的复杂性可能会影响脂质体的溶解度,膜的相变温度,平均粒径以及相关的粒径分布,并可能影响药物的封装和释放。通过对可混溶液体的混合进行精确的稳态控制和高效的热传递,微流体技术已被证明是生产脂质体的有效且直接的方法。与标准工业方法相比,此方法在减少上浆步骤的数量方面特别有效。在这里,微流体水力聚焦芯片被生产出来,并在调整实验参数(例如脂质浓度和流率比率(FRR))后用于形成脂质体。尽管建模证明层流对几何约束和FRR条件的依赖性,但对于本研究中研究的特定制剂,脂质浓度被确定为影响脂质体大小及其多分散指数的主要因素。这归因于所使用的脂质混合物中弯曲弹性模量超过囊泡指数的优势。最终,使用微流体单锅合成法以连续流动的方式生产了可注射大小的脂质体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号